The RYR3 (Ryanodine Receptor 3) gene encodes a calcium release channel protein that plays a critical role in intracellular calcium signaling. As one of three ryanodine receptor isoforms, RYR3 is expressed throughout the brain and is implicated in various neurological disorders, including Alzheimer's disease, Parkinson's disease, and epilepsy.
The RYR3 (Ryanodine Receptor 3) gene encodes a calcium release channel protein that plays a critical role in intracellular calcium signaling. As one of three ryanodine receptor isoforms, RYR3 is expressed throughout the brain and is implicated in various neurological disorders, including Alzheimer's disease, Parkinson's disease, and epilepsy.
Overview
Mermaid diagram (expand to render)
Function
Calcium Release Channel
RYR3 is a large intracellular calcium release channel primarily located on the endoplasmic reticulum (ER) membrane. Like other ryanodine receptor isoforms (RYR1 and RYR2), RYR3 forms a massive tetrameric channel complex that regulates calcium release from ER stores.
Channel Structure
N-terminal cytoplasmic domain: Multiple SPRY domains and FKBP binding sites
Transmembrane domain: Six transmembrane helices forming the channel pore
C-terminal channel domain: Forms the Ca²⁺ conduction pathway
Calcium Signaling Roles
RYR3 participates in several critical neuronal functions:
Synaptic plasticity: Calcium release through RYR3 modulates [long-term potentiation](/mechanisms/long-term-potentiation) (LTP) and long-term depression (LTD)
Calcium dysregulation through RYR3 may accelerate [tau](/proteins/tau) phosphorylation[@laferla2002]
Hyperphosphorylated tau further disrupts calcium homeostasis
Creates a vicious cycle of neurodegeneration
Parkinson's Disease
RYR3 alterations are also implicated in PD:
Dopaminergic neuron vulnerability: RYR3-mediated calcium dysregulation may contribute to selective vulnerability of substantia nigra neurons[@stutzmann2007]
Mitochondrial dysfunction: RYR3 alterations compound mitochondrial defects in PD
[Alpha-synuclein](/proteins/alpha-synuclein) interaction: Calcium dysregulation may accelerate alpha-synuclein aggregation
Epilepsy
RYR3 is associated with epilepsy:
Seizure susceptibility: Altered RYR3 function may lower seizure thresholds
Temporal lobe epilepsy: RYR3 expression changes in hippocampal neurons
Excitotoxicity: Dysregulated calcium release contributes to excitotoxic cell death
Bipolar Disorder
RYR3 has been linked to bipolar disorder through genetic studies[@werner2012]
Calcium signaling abnormalities are a hallmark of the disorder
Expression
Brain Regions
RYR3 is widely expressed in the central nervous system:
[Hippocampus](/brain-regions/hippocampus) — CA1-CA3 regions, dentate gyrus (critical for learning and memory)
Cerebral [cortex](/brain-regions/cortex) — Layers II-IV, particularly in pyramidal neurons
Cerebellum — Purkinje cells and granule cells
Thalamus — Relay nuclei
Basal ganglia — Striatum, substantia nigra
Cellular Expression
Neurons: RYR3 expressed in excitatory glutamatergic and inhibitory GABAergic neurons
[Astrocytes](/entities/astrocytes): Lower expression in glial cells
[Microglia](/cell-types/microglia-neuroinflammation): Limited expression under normal conditions
Pathogenic Mechanisms
Calcium Overload
Dysregulated RYR3 function leads to calcium overload through several mechanisms:
Channel hyperactivity: Mutations or alterations can cause excessive channel opening
Gene therapy: Approaches to normalize RYR3 expression
Combination therapies: Targeting RYR3 with disease-modifying agents
Cross-References
[Calcium Signaling in Neurodegeneration](/mechanisms/calcium-signaling-neurodegeneration) — Overview of calcium dysregulation
[Alzheimer's Disease](/diseases/alzheimers-disease) — AD mechanisms and RYR3 involvement
[Parkinson's Disease](/diseases/parkinsons-disease) — PD and calcium dysregulation
[Synaptic Plasticity](/mechanisms/synaptic-plasticity) — Role of calcium in synaptic function
Key Publications
[Lanner JT, et al. (2010). Ryanodine receptors: structure and function. J Bioenerg Biomembr](https://doi.org/10.1007/s10863-010-9290-0)[@lanner2010]
[Berridge MJ (2010). Calcium signalling and Alzheimer's disease. Neurochem Res](https://doi.org/10.1007/s11064-010-0323-4)[@berridge2010]
[LaFerla FM (2002). Calcium dyshomeostasis and calcium signalling in Alzheimer's disease. Nat Rev Neurosci](https://doi.org/10.1038/nrn957)[@laferla2002]
[Stutzmann GE (2007). Calcium dysregulation in Alzheimer's disease. Neuroscientist](https://doi.org/10.1177/1073858406294804)[@stutzmann2007]
[Werner AI, et al. (2012). RYR3 variants in bipolar disorder. Mol Psychiatry](https://doi.org/10.1038/mp.2012.50)[@werner2012]
[Zucchi R, et al. (2010). Ryanodine receptor blockers for neurodegenerative diseases. Expert Opin Ther Pat](https://doi.org/10.1517/13543776.2010.497750)[@zucchi2010]
See Also
[RYR3 Protein](/proteins/ryr3-protein) — Protein product page